AI pathology firm Proscia nets $37M investment
Published: June 21, 2022
14th June 2022 – Contribution by Steve Holloway – Featured on Beckers Hospital Review -Proscia, a company that uses artificial intelligence to treat and research cancer, has raised $37 million in series C funding.
Founded in 2014, the data-driven software developer uses digital images rather than microscopes to advance precision medicine and pathology in the oncology field. The company said the funding will help scale its commercial operations, grow its distribution partnerships and expand its sales, marketing and support teams.Share on LinkedIn
Digital PathologyPublished April 2023
This is a brochure for Signify Research’s 2023 report on the global market for Digital Pathology published April 2023.
Find out more